[Experimental synthetic compounds] CYB003 and CYB004

“If psychedelics are ever to be integrated into modern clinical medicine, the usage protocols are as important as the medicines themselves. In this respect Cybin is a leader,” says Dennis J. McKenna

“Cybin has assembled a faculty of top-notch therapists to lead its EMBARK program, which incorporates a multi-dimensional approach to therapies that enable them to be tailored to a variety of patient needs. With the implementation of EMBARK, Cybin is setting high standards for the future of psychedelic therapy.”

Original Article (Business Wire):
Cybin announces publication in frontiers in psychology journal introducing EMBARK, an integrative model of psychedelic therapy
Artwork Fair Use: Jean-Pierre